Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Credit
Loan against securities and Personal loan
Manage alerts
Active alerts for Cohance Lifesciences
Add new alert
COHANCE •
NSE
Cohance Lifesciences
₹456.60
-4.25 (0.92%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
BSE •
9 hours ago
Cohance Lifesciences' Telangana FDF plant inspected by USFDA, 27 Aug-4 Sep 2026. Inspection ended with Form FDA 483; firm initiating CAPA and response submission.
BSE •
2 days ago
Cohance Lifesciences approved investments in NJ Bio and Aruka Bio, totaling USD 18M, to strengthen its ADC strategy. The reorganization increases Cohance's stake in NJ Bio to 67.3% and grants 65% control of Aruka Bio, enhancing integration and pipeline development.
Livesquawk •
1 week ago
Cohance Life saw a Rs 46.35 cr BSE block trade for 1,000,045 shares at Rs 463.5/share.
ScoutQuest •
3 weeks ago
CRISIL Ratings withdrew Cohance Lifesciences' credit ratings upon the company's request. Previous ratings were 'CRISIL BB/Stable' and 'CRISIL A4+ Issuer not cooperating' due to non-cooperation.
ScoutQuest •
1 month ago
Cohance Life surges over 6% amid expectations of Q2 recovery.
Livesquawk •
1 month ago
Goldman Sachs maintains Buy on Cohance with a ₹500 target, citing weak Q1 in Pharma CDMO and Agrochemicals. Recovery is expected from Q2FY27, driven by commercial deliveries, operational normalization, and strategic expansion.
Moneycontrol •
1 month ago
Cohance Lifesciences reported weak Q1 results with a loss of ₹24.1 crore and a 23.1% revenue decline. USFDA inspection of Cohance's Hyderabad plant resulted in five observations, raising regulatory concerns.
ScoutQuest •
1 month ago
Cohance Lifesciences Q1 FY27 reports Rs.4,223M revenue. The company emphasizes strategic growth initiatives.
BSE •
1 month ago
Cohance Lifesciences completed USFDA inspection at its Hyderabad facility with five observations noted. None of the observations relate to data integrity; CAPAs are being prepared for submission.
Livesquawk •
1 month ago
Cohance Lifesciences reports Q1 consolidated net loss of ₹241M. The loss improved compared to ₹489M in the prior year (YoY).